Article
Donor-derived Cell-free DNA: Advancing a Novel Assay to New Heights in Renal Transplantation
4 Feb 2021
Abstract excerpt
Despite advances in transplant immunosuppression, long-term renal allograft outcomes remain suboptimal because of the occurrence of rejection, recurrent disease, and interstitial fibrosis with tubular atrophy. This is largely due to limitations in our understanding of allogeneic processes coupled with inadequate surveillance strategies. The concept of donor-derived cell-free DNA as a signal of allograft stress...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
